Effects of Anthocyans on Cardiovascular and Sympathetic Function
Not Applicable
Completed
- Conditions
- Hypertension
- Registration Number
- NCT00634387
- Lead Sponsor
- Ullevaal University Hospital
- Brief Summary
Anthocyans modify cardiovascular and sympathetic function
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 27
Inclusion Criteria
- Ages 35 to 50 years old
- Males
- Hypertension
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Systolic bloodpressure and heartrate
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie anthocyans' effects on sympathetic nervous system activity in hypertension?
How do anthocyans compare to ACE inhibitors in modulating cardiovascular function in stage 1 hypertension patients?
Are there specific biomarkers that correlate with anthocyan-induced improvements in sympathetic function?
What adverse events are associated with anthocyan supplementation in hypertensive populations?
What combination therapies synergize with anthocyans for sympathetic function modulation in cardiovascular disease?
Trial Locations
- Locations (1)
Cardiovascular and Renal Research Center, Ulleval University Hospital
🇳🇴Oslo, Norway
Cardiovascular and Renal Research Center, Ulleval University Hospital🇳🇴Oslo, Norway